Bibliography
- Singh IP, Bharate SB. Phloroglucinol compounds of natural origin. Nat Prod Rep 2006;23:558-591
- Lafon L. Pharmaceutical compositions containing phloroglucinol. GB904955; 1962
- Bennis A, Serrano J-J, Bennis F. Pharmaceutical compositions for oral administration of phloroglucinol and preparation thereof. HK1045937; 2004
- Bennis A, Serrano J-J, Bennis F. Pharmaceutical compositions for oral administration of phloroglucinol and preparation thereof. US6716884; 2004a
- Orsymonde. Pharmaceutical compositions comprising phloroglucinol ethers. GB1272562; 1972
- Ham IG, Kim GT, Kim SG, et al. New spasmolytic agent containing phloroglucinol as effective ingredient. KR20020045948; 2002
- Dubois J, Frayssinet L. Compositions containing ibuprofen and phlorogluicnol. FR2735025; 1966
- Lafon V. Improvements in or relating to phloroglucinol and derivatives. GB1276097; 1972
- Vaille M. Improvements in or relating to phloroglucinol and derivatives. GB1271519; 1972
- Lafon L. Improvements in or relating to phloroglucinol and derivatives. GB1262785; 1972
- Chan JA, Westley JW. Anti-viral compositions. WO9109595; 1991
- Tada M, Seta A, Kuribayashi Y, et al. Anti-Herpes virus agent. JP4128220; 1992
- Tada M, Seta A, Kuribayashi Y, et al. Anti-Herpes virus agent. JP4124129; 1992a
- Kapadia GJ. Antimalarial agents. US5807898; 1998
- Meyer JJM, Mathegka ADM. Phloroglucinol compounds. WO0123342; 2001
- Courtney WJ. Anti-microbial composition comprising Leptospermum scoparium and Melaleuca alternifolia oils. WO0027206; 2000
- Nagayama K, Hirayama I, Nakamura T, et al. Anti-bacterial agents based on phlorotannins. JP2001199881; 2003
- Choi JS, Jung HY, Jung JH, et al. Composition comprising phlorotannin isolated from extract of Ecklonia stolonifera Okamura having anti-oxidant activity, wherein the phlorotannin effectively scavenges free radicals. KR20040095125; 2004
- Miyazaki T, Shiojiri M. Urease inhibitor. JP2006241039; 2006
- Nagayama K, Kimura T, Hirayama I, et al. Antiviral agent. JP2004189648; 2004
- Byun YR, Hwang JK, Park JH. Antibacterial agent and oral composition containing panduratin derivatives for prevention and treatment of dental carries and periodontitis. KR20030060440; 2003
- Tobe H, Muraki Y, Arai S. Therapeutic agent for infectious disease with methicillin-resistant Staphylococcus aureus. JP7228527; 1995
- Tagashira M. Utilization of humulones having antioxidant action. JP6312924; 1994
- Tagashira M. Utilization of mallophenone having antioxidant action and its production. JP8026981; 1996
- Broadbent JL, Bowden K, Ross WJ. 2,4-Diloweralkanoyl phloroglucinol derivatives. US3467715; 1969
- Goupil J-J. 5-Methoxy-psoralen used to treat psoriasis. US5360816; 1994
- Goupil J-J. 5-Methoxy-psoralen as new medicament and process for the synthesis thereof. US5405868; 1995
- Puybaret C, David B, Charveron M, et al. Extract of myrtle containing acylphloroglucinols, especially myrtucommulone B′, for treating psoriasis and keratinization disorders. FR2783425; 2000
- Bertini CS. Drug and method for increasing the microcirculatory flow-rate and volume in the capillaries to the skin. US5280020; 1994
- Breton L, Girerd F, Renault B. Promoting epidermal renewal with phloroglucinol. US006054137A; 2000
- Lee JN, Jeong JH, Kee B, et al. Cosmetic composition comprising extract from Mallotus japonicus for improving skin wrinkle. US2007053863A1; 2007
- Leon JLMD. Cell regenerator. MX03000020; 2005
- Lescroart P. Nerve damage. WO2005107744; 2005
- Lescroart P. Aminoketone derivatives of phloroglucinol for the treatment of motor neuron disease. GB2414665; 2005
- Tobe H, Kitamura K. Pharmaceutical composition for treating osteoporosis. EP0677289A2; 1995
- Lafon L. New phloroglucinol derivatives, their method of preparation and their use as pharmaceuticals. GB2004883; 1979
- AbbottLab. Tri-cyclic compounds derived from phloroglucinal. GB1510431; 1978
- Maillard J, Vincent M, Delaunay P. Therapeutic compositions containing phloroglucinol derivatives, new derivatives of phloroglucinol and process for preparing the same. GB1067575; 1967
- Boucard M. Improvements in or relating to 2,4,6-trihydroxy-benzoic acid and its derivatives. GB042835; 1966
- Yamamoto K, Saegusa H, Hiramitsu M, et al. Apoptosis inducer. JP2001199881; 2001
- Tada K, Chiba K, Kojima H, et al. Allergic disorder therapeutic agent. JP4108730; 1992
- Tada K, Chiba K, Kojima H, et al. 2,6-diacyl-4,4-dialkylcyclohexane-1,3, 5-trione and allergic disorder therapeutic agent with the same as active ingredient. JP108729; 1992
- Bae JH, Lee CH, Lee HU, et al. Composition to improve sexual dysfunction. KR2004008166; 2004
- Strong AH, Levy J, Huber G, et al. Formulation for visual acuity amelioration by photodynamic therapy of eye. JP2006273853; 2006
- Newmark T, Schulick P. Herbal composition and method for promoting emotional well-being. US2002107172; 2002
- Castor TP. Formulations for hyperforin-enriched hypericum fractions. US2006240098; 2006
- Duan ZG. An oral administered medicine for treating depression – Jin Yu Kang. CN875954; 2006
- Zhang M, Duan Z, Guo S. Jinyukang – oral medicine for curing depression. CN408396; 2003
- Bombardelli E. Compounds useful in the therapy of Alzheimer's disease and formulations containing them. US2007010507; 2007
- Timothy HMD. Combinations of St. John's Wort and fatty acids. WO0033831; 2000
- Bombardelli E, Morazzoni P, Riva A, et al. Hyperforin derivatives, the use thereof and formulations containing them. HK1075654; 2007
- Bombardelli E, Morazzoni P, Riva A, et al. Hyperforin halogenated derivatives, the use thereof and formulations containing them. HK1075653; 2006
- Bombardelli E, Morazzoni P. Hyperforin derivatives, the use thereof and formulations containing them. HK1036791; 2006
- Erdelmeier C, Grethlein E, Lang F, et al. Stable dry extract of Hypericum perforatum L., Saint John's Wort – with stabiliser and higher hyperforin content, used to treat depression and psycho-vegetative illness, obtained by solvent extraction etc. DE19619512; 1997
- Erdelmeier C, Grethlein E, Lang F, et al. Stable extract of Hypericum perforatum L., a method for producing the same, and corresponding pharmaceutical preparations. US6241988; 2001
- Erdelmeier C, Grethlein E, Lang F, et al. Stable extract of Hypericum perforatum L., process for preparing the same and pharmaceutical compositions. US6280736; 2001
- Erdelmeier C, Grethlein E, Lang F, et al. Stable extract of Hypericum perforatum L., processes for its preparation and pharmaceutical compositions. TW471969B; 2002
- Chatterjee SS, Erdelmeier C, Stumpf H. St. John's Wort dry extract, process for its preparation and its use. EP0599307; 1994
- Bombardelli E, Morazzoni P. Hyperforin derivatives, the use thereof and formulations containing them. SI1086071T; 2006a
- Luo M. Hypericum perforatum L. phenolic acid and injection thereof preparation method CN1883520; 2006
- Simon JC, Schempp CM, Schoepf E, et al. Hyperforin as cytostatic agent and hyperforin ointment or cream as application form. US7179495; 2007
- Schempp CM, Simon J, Schoepf E. Use of hyperforin for treating cancer, or in topical compositions optionally together with hypericin for treating e.g. inflammatory skin disease, skin aging or bacterial skin infections. DE19854446; 2000a
- Schempp C, Simon JC, Simon-haarhaus B, et al. Hyperforin as cytostatic agent and hyperforin ointment or cream as application form. EP1275382; 2003
- Schempp C, Simon-Haarhaus B, Simon JC. Use of hyperforin for treating cancer, or in topical compositions optionally together with hypericin for treating e.g. inflammatory skin disease, skin aging or bacterial skin infections. DE19913333; 2000
- Irion KM, Beck G. Use of St. John's Wort constituents for photodynamic diagnosis and/or therapy of mouth and malignant brain disorders. DE19950933; 2001
- Roots I, Krusekopf S. Use of hyperforin or St. John's Wort in the treatment and prevention of metabolic syndrome. EP1774974; 2007
- Schempp C, Jocher A, Engel K, et al. Pharmaceutical compositions from beard lichen (Usnea barbata) and St. John's Wort (Hypericum perforatum) and their use. WO2005099728; 2005
- Joachim H. Improved and stable extract from Hypericum perforatum L. MX03005657; 2004
- Schempp CM, Simon JC. Use of hyperforin and derivatives thereof for inhibiting angiogenesis. WO03094945; 2003
- Werz O, Albert D, Steinhilber D, et al. Use of hyperforin or St John's Wort extracts against anaphylactic states of shock and for maintaining and improving bone health. WO03053456; 2003
- Sutherland SK, Shan JJ. Antioxidant and Fe2+chelating properties of herbal extracts. WO2007045959; 2007
- Chatterjee SS, Erdelmeier C, Klessing K, et al. Stable hyperforin salts, method for producing same and their use in the treatment of Alzheimer's disease. US6444662; 2002
- Chancellor MB, Tyagi P, Kaufman J. Active agent and formulations to minimize or alleviate bladder urgency and irritation and/or to enhance sexual function. US2007028930; 2007
- Rizzi GP. Novel dihydrochalcone sweetener compositions. US3932678; 1976
- Boehringer. Process for the production of preparation suitable as a blood plasma substitute. GB736354; 1955
- Roussel U. Improvements in or relating to the purification of vitamin B12. GB833067; 1960
- Tomas-lorente F, Iniesta-Sanmartin E, Tomas-Barberan F, et al. Phloroglucinol derivatives. DE3907543; 1990
- Lin C-N, Wang J-P, Weng J-R. Anti-inflammatory and cure for ageing, Alzheimer's disease on phloroglucinol derivatives. US2006205808; 2006
- Aino K, Maki H, Shimizu K, et al. Method for producing antimicrobial substance: 2,4-diacetylphloroglucinol. JP7187938; 1995
- Saeki T, Osawa K, Yasuda H. Angiotensinase inhibitor and angiotensinase inhibitory food/drink with the same as active ingredient. JP11060498; 1999
- Osawa K, Yasuda H. Anti-carious and anti-periodontopathic agent and composition for oral cavity containing the same. JP8109118; 1996
- Osawa K, Yasuda H. Preventing and therapeutic agent for throat inflammation and hemolysin and composition for oral cavity containing the same. JP8259452; 1996
- Tamaoki Y, Kato T, Miyake Y. Anti-microbial agent. JP8027005; 1996
- Kitanaka S, Daikonya A, Arisawa M, et al. Anti-allergic agent and anti-inflammatory agent using fluoroglycinol, derivative. JP2003073265; 2003
- Kitanaka S, Daikonya A, Katsuki S. New phloroglucinol derivative, composition given by using the same, and anti-allergenic agent. JP2003055369; 2003
- Chatterjee SS, Erdelmeier C, Noeldner M. Use of hyperforin and hyperforin-containing extracts in the treatment of dementia diseases. US6322824; 2001
- Singer A, Wonnemann M. Treatment of depression by using compounds which elevate the intracellular sodium concentration EP1034782; 2000
- Quintanilla AE, Ramirez BA, Abernd A, et al. Hypericum Perforatum L. oleoresin, procedure for obtaining it and uses of it. US2002197337; 2002
- Stumpf K-H, Erdelmeier C, Oschmann R, et al. Stable preparations with hyperforin. EP1126882; 2001
- Stumpf K-H, Erdelmeier C, Oschmann R, et al. Stabile Zubereitungen mit Hyperforin. DE19903570; 2000
- Yang D, Wang F, Huang S. Extracting and purifying method for Hypericum perforatum component in plant. CN1392130; 2003
- Yang D, Wang F, Huang Y. Process for preparing Hypericum perforatum extract. CN1392129; 2003
- Li X. Extracting technology for medicinal hyperforin as plant product. CN1473812; 2004
- Lanquetin M, Rougaignon C, Viant P. Extraction of active principles from plants to increase the rate and to ensure the stabilization of acylphloroglucinol, comprises subjecting the extracts in a suitable pH zone followed by drying in vacuum at low temperature on zeolite. FR2894829; 2007
- Erdelmeier C, Grethlein E, Lang F, et al. Stable extract of Hypercium perforatum L., processes for its preparation and pharmaceutical compositions US2002031560; 2002
- Available from: www.herbalremedies.com
- Available from: http://www.researchandmarkets.com
- Bharate SB, Bhutani KK, Khan SI, et al. Biomimetic synthesis, antimicrobial, antileishmanial and antimalarial activities of euglobals and their analogues. Bioorg Med Chem 2006;14:1750-60
- Bharate SB, Khan SI, Yunus NAM, et al. Antiprotozoal and antimicrobial activities of O-alkylated and formylated acylphloroglucinols. Bioorg Med Chem 2007;15:87-96
- Bharate SB, Khan SI, Tekwani BL, et al. S-Euglobals: Biomimetic synthesis, antileishmanial, antimalarial, and antimicrobial activities. Bioorg Med Chem 2008;16:1328-36